Intuitive Surgical (ISRG)
has garnered ample attention for its daVinci surgical robots - both
from investors who lust for Intuitive's revenue and earnings growth, and
clinicians looking to either use or question the use of these surgical
robots. A recent paper once again highlighted the obvious -
robot-assisted surgeries cost more - but a closer look at the details of
what the paper did, and did not, say suggests minimal incremental risk
to Intuitive Surgical.
Please read more here:
A New Paper At JAMA Unlikely To Jam Up Intuitive Surgical
1 comment:
Stephen,
Good read on this study. It got some discussion of TMF boards, but your take was more thorough than others I read. In studies like this, I also like to see some look at a follow up period. Days in hospital were looked at, but not # of follow on office visits or related rehospitalizations in the next 6 months. There may not have been much difference here (?) but the costs can be significant and often under appreciated.
Post a Comment